Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Eric W. Roberts | CHIEF BUSINESS OFFICER | 2024-04-02 | 3,254 | $3.90 | $12.69kBuy |
Eric W. Roberts | CHIEF BUSINESS OFFICER | 2024-04-01 | 746 | $3.90 | $2.91kBuy |
Eric W. Roberts | CHIEF BUSINESS OFFICER | 2024-02-05 | 91,086 | $4.27 | $388.57kBuy |
Sanderling Venture Partners Vi LP | 10% Owner | 2024-01-23 | 194,472 | $3.70 | $719.94kBuy |
Sanderling Venture Partners Vi LP | 10% Owner | 2024-01-23 | 51,032 | $3.70 | $188.92kBuy |
Sanderling Venture Partners Vi LP | 10% Owner | 2024-01-23 | 13,184 | $3.70 | $48.81kBuy |
Sanderling Venture Partners Vi LP | 10% Owner | 2024-01-23 | 3,920 | $3.70 | $14.51kBuy |
Sanderling Venture Partners Vi LP | 10% Owner | 2024-01-23 | 28,744 | $3.70 | $106.41kBuy |
Fred A. Middleton | Director | 2024-01-23 | 28,744 | $3.70 | $106.41kBuy |
Sanderling Venture Partners Vi LP | 10% Owner | 2024-01-23 | 243,356 | $3.70 | $900.90kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
James E. Flynn | 49.18% | 5,281,713 | $23.85M | Insider |
Orbimed Advisors LLC | 38.76% | 4,163,347 | $18.80M | Insider |
Fred A. Middleton | 28.33% | 3,042,706 | $13.74M | Insider |
Sanderling Venture Partners Vi LP | 21.60% | 2,319,428 | $10.47M | Insider |
Clarus Lifesciences Iii LP | 17.97% | 1,930,395 | $8.72M | Insider |
Christy L. Shaffer | 14.96% | 1,606,669 | $7.25M | Insider |
Hansoo Michael Keyoung | 10.55% | 1,133,596 | $5.12M | Insider |
Eric W. Roberts | 8.44% | 906,477 | $4.09M | Insider |
A. Rachel Leheny | 7.92% | 850,252 | $3.84M | Insider |
Valence Investments Spv Iv LLC | 6.88% | 739,326 | $3.34M | Insider |